High burden and low awareness of toxoplasmosis in the United States
| Autor: | Mark P. Connolly, Ruben R Ben-Harari |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Health Knowledge Attitudes Practice Prevalence 030209 endocrinology & metabolism Disease 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Cost of Illness Environmental health parasitic diseases Epidemiology Health care medicine Humans Disease burden biology business.industry Public health Toxoplasma gondii General Medicine medicine.disease biology.organism_classification Toxoplasmosis United States business Toxoplasma |
| Zdroj: | Postgraduate medicine. 131(2) |
| ISSN: | 1941-9260 |
| Popis: | Toxoplasmosis, a disease with diverse clinical manifestations, caused by infection with the Apicomplexan parasite, Toxoplasma gondii (T. gondii), is a major source of morbidity and mortality in the United States. Although toxoplasmosis prevalence and mortality have declined over the past two decades, the CDC considers this disease a neglected parasitic infection requiring public health action. Here, we overview the literature to bring attention to the prevalence of the disease in the United States, and high economic burden associated with the disease. The conclusions to be drawn are clear: there is low awareness and underestimation of the disease burden amongst healthcare professionals; a high economic burden associated with the disease; relapse rates to treatment represent additional mortality and morbidity and further costs for the healthcare system; and better treatments are necessary to combat this public health threat. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|